| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 01/16/2013 | CN102875528A Quinolone metal complex containing polyacid anion and preparation method thereof |
| 01/16/2013 | CN102875527A Preparation method of desloratadine |
| 01/16/2013 | CN102875467A 1,3-disubstituted-3-diazabicyclo[3,3,1] nonane derivative and preparation method thereof |
| 01/16/2013 | CN102875466A Isoquinolinone derivatives, and preparation method and medical purpose thereof |
| 01/16/2013 | CN102875464A 3-Schiff base-2(1H)-quinolinone derivative and preparation method and application thereof |
| 01/16/2013 | CN102875441A Plexxikon inc |
| 01/16/2013 | CN102875413A 免疫抑制剂化合物及组合物 Immunosuppressant compounds and compositions |
| 01/16/2013 | CN102180865B Synthesis method of lansoprazole |
| 01/16/2013 | CN101921260B Method for preparing imatinib |
| 01/16/2013 | CN101921236B 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 01/16/2013 | CN101747253B Trisubstituted chiral lactam derivative and preparation method and application thereof |
| 01/16/2013 | CN101730690B Sulfonamide compound, and crystal thereof |
| 01/16/2013 | CN101678129B Radioactive pet agents for imaging CCR5 in vivo |
| 01/16/2013 | CN101405270B Pyrazoles as 11-beta-HSD-1 |
| 01/16/2013 | CN101128455B Heterocyclylamide-substituted imidazoles |
| 01/15/2013 | USRE43932 Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
| 01/15/2013 | US8354545 3,4-substituted pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/15/2013 | US8354541 Optical purification of esomeprazole |
| 01/15/2013 | US8354540 2-aminopyridine analogs as glucokinase activators |
| 01/15/2013 | US8354539 Indole derivatives as IKK2 inhibitors |
| 01/15/2013 | US8354538 Small-molecule inhibitors of the androgen receptor |
| 01/15/2013 | US8354537 R,R1-atracurium salts |
| 01/15/2013 | US8354535 Salts of 6-heterocycle substituted hexahydrophenanthridine derivatives |
| 01/15/2013 | US8354529 Polyamine derivative and polyol derivative |
| 01/15/2013 | US8354434 Cyclourea compounds as calcium channel blockers |
| 01/15/2013 | US8354432 Cyclic derivatives as modulators of chemokine receptor activity |
| 01/15/2013 | US8354431 Aryl carboxylic acid cyclohexyl amide derivatives |
| 01/15/2013 | US8354429 Inhibitors of human immunodeficiency virus replication |
| 01/15/2013 | US8354423 Insecticidal spironindane derivatives |
| 01/15/2013 | US8354419 Benzimidazole analogues for the treatment or prevention of flavivirus infections |
| 01/15/2013 | US8354411 1-phenyl-3-pyrazolylpyridazin-4(1H)-one compound |
| 01/15/2013 | US8354406 Chemical compounds |
| 01/15/2013 | US8354402 Polyarylcarboxamides useful as lipid lowering agents |
| 01/15/2013 | US8354399 Substituted indazole derivatives active as kinase inhibitors |
| 01/15/2013 | CA2702834C Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof |
| 01/15/2013 | CA2693997C Viral polymerase inhibitors |
| 01/15/2013 | CA2586702C Vinylaminopyrazole derivatives as pesticides |
| 01/15/2013 | CA2547391C Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 01/15/2013 | CA2524161C Pyridinyl acetonitriles |
| 01/10/2013 | WO2013006738A1 Compounds for the treatment of hiv |
| 01/10/2013 | WO2013006308A2 Dihydropyrazoles |
| 01/10/2013 | WO2013005798A1 Novel nitrogenated heterocyclic ring derivative |
| 01/10/2013 | WO2013004996A1 5- or 6 - substituted 3 - hydroxy - 2 ( 1h) - pyridinones as d-amino acid oxidase (daao) inhibitors in therapy of diseases such as schizophrenia, cognitive disorder and pain |
| 01/10/2013 | WO2013004709A1 Indolylmaleimides as soft pan-pkc inhibitors |
| 01/10/2013 | WO2013004332A1 Substituted azaheterocycles for the treatment of cancer |
| 01/10/2013 | WO2012156756A3 Macrocyclic compounds as protein kinase inhibitors |
| 01/10/2013 | WO2012141554A3 Complex in which an anti-cotinine antibody is bound to a binder material of cotinine and a binding substance, and a use therefor |
| 01/10/2013 | WO2012128512A3 Cobalt-based compound for a solar cell |
| 01/10/2013 | WO2012101065A3 Pyrimidine biaryl amine compounds and their use as cdk9 inhibitors |
| 01/10/2013 | US20130012715 Pyrazole synthesis by coupling of carboxylic acid derivatives and enamines |
| 01/10/2013 | US20130012714 Novel solvate of dexlansoprazole |
| 01/10/2013 | US20130012713 Compound containing pyridine ring and method for producing halogenated picoline derivative and tetrazolyloxime derivative |
| 01/10/2013 | US20130012711 Substituted phenyl compounds |
| 01/10/2013 | US20130012709 NOVEL INHIBITORS OF STEAROYL-CoA-DESATURASE-1 AND THEIR USES |
| 01/10/2013 | US20130012705 Dicycloazaalkane derivatives, preparation processes and medical uses thereof |
| 01/10/2013 | US20130012704 Compounds and compositions as protein kinase inhibitors |
| 01/10/2013 | US20130012547 Insecticidal compounds |
| 01/10/2013 | US20130012546 Fungicide hydroximoyl-tetrazole derivatives |
| 01/10/2013 | US20130012544 Pyrazolone derivatives as pde4 inhibitors |
| 01/10/2013 | US20130012543 Cytoskeletal active rho kinase inhibitor compounds, composition and use |
| 01/10/2013 | US20130012541 Therapeutic Agents Useful for Treating Pain |
| 01/10/2013 | US20130012540 Hepatitis C Virus Inhibitors |
| 01/10/2013 | US20130012532 Cyclopropanecarboxylic acid derivative |
| 01/10/2013 | US20130012522 New derivatives of propargylamine having neuroprotective capacity for the treatment of alzheimer's and parkinson's diseases |
| 01/10/2013 | US20130012521 Apoptosis signal-regulating kinase inhibitors |
| 01/10/2013 | US20130012515 Fused Bicyclic Pyridine and Pyrazine Derivatives as Kinase Inhibitors |
| 01/10/2013 | US20130012512 P38 MAP kinase inhibitors |
| 01/10/2013 | US20130012511 Soluble guanylate cyclase activators |
| 01/10/2013 | US20130012504 Bi-functional quinoline analogs |
| 01/10/2013 | US20130012503 Metalloenzyme inhibitor compounds |
| 01/10/2013 | US20130012499 Trpv4 antagonists |
| 01/10/2013 | US20130012493 Novel spiro imidazolone derivatives as glucagon receptor antagonists, compositions, and methods for their use |
| 01/10/2013 | US20130012491 Pyrimidine derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonists |
| 01/10/2013 | US20130012490 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators |
| 01/10/2013 | US20130012485 Organic compounds |
| 01/10/2013 | US20130012479 Polymorphs of 6-(piperidin-4-yloxy)-2h-isoquinolin-1-one hydrochloride |
| 01/10/2013 | US20130012444 Crystalline solvates of 6-(piperidin-4-yloxy)-2h-isoquinolin-1-one hydrochloride |
| 01/10/2013 | US20130012380 Pyridazine Compounds For Controlling Invertebrate Pests |
| 01/10/2013 | US20130011361 Pyrazole derivatives which modulate stearoyl-coa desaturase |
| 01/10/2013 | US20130009543 Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device |
| 01/10/2013 | US20130009142 Charge transport compositions and electronic devices made with such compositions |
| 01/10/2013 | CA2840883A1 Substituted azaheterocycles for the treatment of cancer |
| 01/10/2013 | CA2840095A1 Compounds for the treatment of hiv |
| 01/10/2013 | CA2837524A1 Dihydropyrazoles |
| 01/09/2013 | EP2544257A1 Material for organic electroluminescent element, and organic electroluminescent element using same |
| 01/09/2013 | EP2543665A2 Crystalline forms of 4-methyl-n-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide free base |
| 01/09/2013 | EP2542548A1 Process for preparation of polymorphic form and new polymorphic form of imatinib mesylate isolated in that process |
| 01/09/2013 | EP2542538A1 6-acyl-1,2,4-triazine-3,5-dione derivative and herbicides |
| 01/09/2013 | EP2542536A1 Morpholino substituted urea derivatives as mtor inhibitors |
| 01/09/2013 | EP2542530A2 Process for the preparation of 2-(cyclohexylmethyl)-n-{2- [(2s)-1-methylpyrrolidin-2-yl]ethyl}-1, 2, 3, 4- tetrahydroisoquinoline-7-sulfonamide |
| 01/09/2013 | EP2542528A1 Heterocyclic amides as rock inhibitors |
| 01/09/2013 | EP2542525A1 Cationic 6-aminoindolines, dyeing compositions containing them, processes and uses thereof |
| 01/09/2013 | EP2542524A1 Derivatives of aminoindanes, their preparation and their application in therapeutics |
| 01/09/2013 | EP2542089A1 Nuclear transport modulatiors and uses thereof |
| 01/09/2013 | EP2542077A1 Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders |
| 01/09/2013 | CN102869657A Analogues for the treatment or prevention of flavivirus infections |
| 01/09/2013 | CN102869647A Sulfone compounds as 5-ht6 receptor ligands |
| 01/09/2013 | CN102863446A Preparation of pyrrole and pyrrolin fused ring compound with insecticidal activity and use thereof |
| 01/09/2013 | CN102863428A Spiro-compounds taken as hepatitis c virus (HCV) inhibitor |
| 01/09/2013 | CN102863427A Organic electroluminescence device, novel platinum complex compound and novel compound capable of being a ligand thereof |